ACOR
Acorda Therapeutics
ACOR
ACOR
Delisted
ACOR was delisted on the 11th of April, 2024.
175 hedge funds and large institutions have $1.23B invested in Acorda Therapeutics in 2016 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 86 increasing their positions, 47 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
53% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 34
87% less call options, than puts
Call options by funds: $2.53M | Put options by funds: $19.3M
Holders
175
Holding in Top 10
2
Calls
$2.53M
Puts
$19.3M
Top Buyers
| 1 | +$22.1M | |
| 2 | +$19.4M | |
| 3 | +$17.9M | |
| 4 |
Westfield Capital Management
Boston,
Massachusetts
|
+$16.1M |
| 5 |
SCM
Scopia Capital Management
New York
|
+$13.2M |
Top Sellers
| 1 | -$25.2M | |
| 2 | -$13.2M | |
| 3 | -$12.7M | |
| 4 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
-$12.6M |
| 5 |
PCM
Penn Capital Management
Philadelphia,
Pennsylvania
|
-$9.18M |